Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Reason / purpose for cross-reference:
reference to same study
Reason / purpose for cross-reference:
reference to other study
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.6 (Skin Sensitisation)
Deviations:
no
Principles of method if other than guideline:
Not applicable
Justification for non-LLNA method:
The study was performed before the OECD guideline 429 was used as standard method for regulatory purposes.
Species:
guinea pig
Strain:
Hartley
Sex:
male/female
Route:
intradermal and epicutaneous
Route:
epicutaneous, occlusive
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
10 %
No. with + reactions:
2
Total no. in group:
20
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 10 %. No with. + reactions: 2.0. Total no. in groups: 20.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
10 %
No. with + reactions:
2
Total no. in group:
20
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 10 %. No with. + reactions: 2.0. Total no. in groups: 20.0.
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
10 %
No. with + reactions:
1
Total no. in group:
10
Clinical observations:
Dryness of skin
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 10 %. No with. + reactions: 1.0. Total no. in groups: 10.0. Clinical observations: Dryness of skin.
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
10 %
No. with + reactions:
1
Total no. in group:
10
Clinical observations:
Dryness of skin
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 10 %. No with. + reactions: 1.0. Total no. in groups: 10.0. Clinical observations: Dryness of skin.
Group:
positive control
Remarks on result:
positive indication of skin sensitisation

Table 1: range-finding test by intradermal route

Animal

number

Concentration of the

test item % (w/w)

Scoring after treatment

24 hours

48 hours

6 days

female 301

10 + FCA

I

A

A

 

10

LI

I

I

 

5 + FCA

I

A

A

 

5

LI

I

I

female 302

10 + FCA

I

A

N

 

10

I

I

A

 

5 + FCA

I

A

A

 

5

LI

I

I

male 305

1 + FCA

I

I

A

 

1

LI

LI

LI

 

0.1 + FCA

I

I

I

 

0.1

LI

LI

LI

female 306

1 + FCA

I

I

A

 

1

LI

LI

LI

 

0.1 + FCA

I

I

I

 

0.1

LI

LI

LI

FCA : mixture Freund's Complete Adjuvant/0.9% NaCl (50/50, v/v)

N : necrosis

I : irritation

LI : slight irritation

A : crusts

Table 2: Range-finding test by topical application

Under the conditions of the induction phase

Animal

number

Concentration of the

test item % (w/w)

Scoring after removal of the dressing

24 hours

48 hours

female 303

50

3/A

3/A/Oe

female 304

25

3/A

LS/A/Oe

male 307

10

0

0

female 308

5

0

0

A : crusts

LS : scoring masked by dryness of the skin

Oe : oedema

Under the conditions of the challenge phase

Animal

number

Concentration of the

test item % (w/w)

 

Scoring after removal of the dressing

24 hours

48 hours

female 301

50

RF

2

2/S

25

LF

1

0

female 302

50

RF

2

2/S

25

LF

1

1

male 305

10

RF

0

0

5

LF

0

0

female 306

10

RF

0

0

5

LF

0

0

RF : right flank

LF : left flank

S : dryness of the skin

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

In a GLP skin sensitization test in guinea pigs, conducted according to OECD guideline 406, 2 out of 20 animals in Chimexane NV treated group and 1 animal in control group had positive reactions at both 24 and 48 h readings.


Migrated from Short description of key information:
In a GLP skin sensitization test in guinea pigs conducted according to OECD guideline 406, Chimexane NV elicited positive response in 2 out of 20 animals in test group at both 24 and 48 h readings.

Justification for selection of skin sensitisation endpoint:
Only one study available for this endpoint

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

As less than 30% of total tested animals had positive response in a maximisation test, it is concluded that Chimexane NV does not need to be classified as skin sensitiser according to the Annex VI to the Directive 67/548/EEC and the CLP Regulation (EC) N° (1272 -2008).